Pharmaceuticals, Biotechnology and Life Sciences
A recombinant ‘ACE2 Decoy’ shows robust binding to current SARS-CoV-2 variants and potential to outsmart viral evolution against antibodies
Traps and neutralizes live SARS-CoV-2 viruses with the potential of a hAd5 ACE2 Decoy to serve both as a the…
Following Record Growth, CRO Continues Dedicated Oncology Team Expansion
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–#BioTech–Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research orga…
Following Record Growth, CRO Continues Dedicated Oncology Team Expansion
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–#BioTech–Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research orga…
Following Record Growth, CRO Continues Dedicated Oncology Team Expansion
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–#BioTech–Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research orga…
– Granted two Fast Track designations for cavrotolimod (AST-008) from the U.S. Food and Drug Administration (FDA) in January 2021 and an Orphan Drug Designation in March 2021
– Commenced IND-enabling studies on XCUR-FXN Friedreich’s ataxia in late 20…
STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #COVID19–Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the receipt of a purchase order for its Linea™ COVID-19 …
Aiming for Revenues of JPY 1 Trillion (approximately US$9 Billion2) by FY2030
Double-Digit Revenue Growth Expected to be Driven by a Balanced and Focused Geographic Presence, Portfolio of 14 Global Brands and Wave 1 Pipeline Assets
Commitment to …
Aiming for Revenues of JPY 1 Trillion (approximately US$9 Billion2) by FY2030
Double-Digit Revenue Growth Expected to be Driven by a Balanced and Focused Geographic Presence, Portfolio of 14 Global Brands and Wave 1 Pipeline Assets
Commitment to …
Speakers from Academia, Large Pharma Collaborations and Regulatory Agencies shared their real-world impact using modeling & simulation technology
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of model…
https://hgpauction.hibid.com/catalog/263633/pss-march-2021–hosted-by-pfizer–100-/
SAN DIEGO–(BUSINESS WIRE)–Heritage Global Partners (“HGP”), a worldwide leader in asset advisory and auction services, and a subsidiary of Heritage Global Inc. (NASD…